companies: 9,622     total market cap: $109.658 T
€EUR🇪🇺₹INR🇮🇳£GBP🇬🇧$CAD🇨🇦$AUD🇦🇺$NZD🇳🇿$HKD🇭🇰$SGD🇸🇬
Novavax
NVAX
#4111
Rank
$2.17 B
Marketcap
🇺🇸 USA
Country
$13.61
Share price
14.18%
Change (1 day)
84.92%
Change (1 year)
💊 Pharmaceuticals🧬 Biotech
Categories

Market capitalization of Novavax (NVAX)

Market cap: $2.17 Billion

As of September 2024 Novavax has a market cap of $2.17 Billion. This makes Novavax the world's 4111th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Novavax from 1996 to 2024

End of year Market Cap

Year Market cap Change
2024$2.17 B282.13%
2023$0.57 B-34.75%
2022$0.87 B-91.92%
2021$10.81 B52.38%
2020$7.09 B5413.03%
2019$0.12 B-81.8%
2018$0.70 B51.97%
2017$0.46 B36.2%
2016$0.34 B-84.91%
2015$2.26 B59.93%
2014$1.41 B32.57%
2013$1.06 B282.07%
2012$0.27 B93.02%
2011$0.14 B-46.31%
2010$0.26 B1.17%
2009$0.26 B104.01%
2008$0.13 B-36.63%
2007$0.20 B-18.57%
2006$0.25 B20.22%
2005$0.21 B63.42%
2004$0.12 B-38.1%
2003$0.20 B220.84%
2002$64.92 M-80.23%
2001$0.32 B74.82%
2000$0.18 B120.23%
1999$85.31 M262.89%
1998$23.5 M-60.86%
1997$60.06 M63.86%
1996$36.65 M

End of Day market cap according to different sources

On Sep 13th, 2024 the market cap of Novavax was reported to be:

$2.17 Billion
by Yahoo Finance info icon info icon
$2.17 Billion
by CompaniesMarketCap info icon info icon
$2.17 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
Agenus
AGEN
$0.13 B-93.80%🇺🇸 USA
Sarepta Therapeutics
SRPT
$11.88 B 445.57%🇺🇸 USA
Emergent BioSolutions
EBS
$0.41 B-80.89%🇺🇸 USA
BioCryst Pharmaceuticals
BCRX
$1.63 B-24.80%🇺🇸 USA
AstraZeneca
AZN
$247.32 B 11,250.96%🇬🇧 UK
Pfizer
PFE
$165.86 B 7,512.37%🇺🇸 USA
Novartis
NVS
$234.16 B 10,646.94%🇨🇭 Switzerland
NanoViricides
NNVC
$19.02 M-99.13%🇺🇸 USA
GlaxoSmithKline
GSK
$88.06 B 3,941.68%🇬🇧 UK
Celldex Therapeutics
CLDX
$2.92 B 34.35%🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
 CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2024 CompaniesMarketcap.com